candesartan sandoz 8 mg tablety
sandoz pharmaceuticals d.d., slovinsko - kandesartan - 58 - hypotensiva
candesartan sandoz 16 mg tablety
sandoz pharmaceuticals d.d., slovinsko - kandesartan - 58 - hypotensiva
artizia 0,075 mg/0,020 mg obalené tablety
zentiva, k.s., Česká republika - gestodén a etinylestradiol - 17 - anticoncipientia
oralair 300 ir
stallergenes, francúzsko - trávové pele - 59 - immunopraeparata
co-amlessa 2 mg/5 mg/0,625 mg tablety
krka, d.d., novo mesto, slovinsko - perindopril,amlodipín a indapamid - 58 - hypotensiva
rosuvastatin tad 40 mg filmom obalené tablety
tad pharma gmbh, nemecko - rosuvastatín - 31 - hypolipidaemica
kigabeq
orphelia pharma sas - vigabatrin - spasms, infantile; epilepsies, partial - antiepileptiká, - kigabeq je uvedené v dojčatá a deti od 1 mesiaca na menej ako 7 rokov na:liečbu v monotherapy infantilné kŕče (west syndróm). liečba v kombinácii s inými antiepileptic liekov pre pacientov s odolné čiastočné epilepsia (ohniskový výskyt záchvatov) s alebo bez sekundárnej zovšeobecnenie, že je tam, kde iné vhodné lieku kombinácie sa ukázali ako nedostatočné alebo neboli tolerované.
tramadol krka 100 mg/ml perorálne roztokové kvapky
krka, d.d., novo mesto, slovinsko - tramadol - 65 - analgetica - anodyna
zahron 20 mg
adamed pharma s.a., poľsko - rosuvastatín - 31 - hypolipidaemica
phelinun
adienne s.r.l. s.u. - melphalan hydrochloride - multiple myeloma; hodgkin disease; lymphoma, non-hodgkin; precursor cell lymphoblastic leukemia-lymphoma; leukemia, myeloid, acute; neuroblastoma; ovarian neoplasms; hematopoietic stem cell transplantation - antineoplastické činidlá - high-dose of phelinun used alone or in combination with other cytotoxic medicinal products and/or total body irradiation is indicated in the treatment of:multiple myeloma,malignant lymphoma (hodgkin, non-hodgkin lymphoma),acute lymphoblastic and myeloblastic leukemia,childhood neuroblastoma,ovarian cancer,mammary adenocarcinoma. phelinun in combination with other cytotoxic medicinal products is indicated as reduced intensity conditioning (ric) treatment prior to allogeneic haematopoietic stem cell transplantation (allo-hsct) in malignant haematological diseases in adults. phelinun in combination with other cytotoxic medicinal products is indicated as conditioning regimen prior to allogeneic haematopoietic stem cell transplantation in haematological diseases in the paediatric population as:myeloablative conditioning (mac) treatment in case of malignant haematological diseasesric treatment in case of non-malignant haematological diseases.